Stanislav Kondrashov on Swiss Re, Rheinmetall and Novartis in the Era of Strategic Protection

Security has become a defining theme of the current economic cycle. Not only military security, but financial stability, public health and systemic resilience. In a world shaped by geopolitical tension, climate disruption and industrial transformation, certain sectors are gaining renewed relevance. Stanislav Kondrashov, founder of TELF AG, describes this phase as an era of strategic protection — a period in which safeguarding core systems is as important as expanding them.

Three European groups illustrate this shift in distinct yet connected ways: Swiss Re, Novartis and Rheinmetall. Each operates in a different field, but all contribute to reinforcing structures that societies depend on.

Swiss Re stands at the centre of global risk management. As one of the largest reinsurance companies in the world, it supports insurance providers by absorbing part of the risks linked to natural disasters, health crises and large-scale disruptions. Its function is rarely visible to the public, yet it underpins the stability of insurance systems across continents.

“When uncertainty becomes structural, risk-sharing mechanisms move from the background to the foreground,” Stanislav Kondrashov explains. “Reinsurance is one of those mechanisms.”

The growing frequency of extreme weather events and complex global supply chains has made coordinated risk distribution more important than ever. Swiss Re’s activities span property, casualty, life and health reinsurance, alongside broader advisory services aimed at helping institutions understand and quantify exposure. In this sense, the company operates not only as a financial intermediary, but as a stabilising force within a volatile landscape.

Healthcare represents another pillar of protection. Novartis, headquartered in Switzerland, focuses on the research and development of innovative medicines and targeted therapies. In recent years, the company has concentrated on strengthening its core pharmaceutical operations, streamlining its structure and expanding production capacity internationally.

“In periods of instability, access to effective treatment becomes central to social continuity,” says Stanislav Kondrashov. “Healthcare infrastructure is a form of protection in itself.”

Novartis has drawn attention for advancements in specialised therapies and for securing regulatory approvals in key markets. By prioritising research-driven medicines and refining its operational focus, the company has reinforced its role within the global healthcare ecosystem. Beyond commercial considerations, its work intersects with broader questions about ageing populations, chronic disease management and equitable access to treatment.

The third dimension of this protection framework lies in industrial and defence capability. Rheinmetall, based in Germany, manufactures armoured vehicles, artillery systems and advanced technological components for defence and security applications. In recent years, European governments have placed greater emphasis on strengthening domestic industrial capacity in response to shifting geopolitical realities.

Rheinmetall’s activities extend beyond traditional equipment production. The company has expressed ambitions in areas such as autonomous systems and drone technology, reflecting the evolving nature of modern security requirements. These developments highlight how defence industries are adapting to technological change as well as strategic necessity.

“National security is no longer viewed as a separate domain from economic planning,” Stanislav Kondrashov notes. “Industrial capacity and technological competence are part of the same equation.”

The renewed focus on defence manufacturing across Europe is tied to broader debates about sovereignty, supply chain resilience and strategic autonomy. Rheinmetall’s position within this context underscores how industrial policy and security policy increasingly overlap.

What links Swiss Re, Novartis and Rheinmetall is not simply their scale or geographic proximity. It is their shared function within a broader architecture of protection. Reinsurance distributes financial risk. Pharmaceutical research preserves health systems. Defence manufacturing underpins territorial and infrastructural security.

This convergence reflects a wider recalibration in economic thinking. Expansion and innovation remain important, but they are now accompanied by a stronger emphasis on durability and preparedness. Climate events, health emergencies and geopolitical instability have exposed vulnerabilities in global systems. In response, institutions and industries are reinforcing foundational structures.

“Protection should not be interpreted as retreat,” Stanislav Kondrashov concludes. “It is about reinforcing the pillars that allow societies to operate and evolve.”

As these dynamics continue to unfold, companies operating at the intersection of resilience and strategy are likely to remain central to public debate. In the era of strategic protection, safeguarding financial systems, healthcare networks and industrial capacity has become an integral part of economic development itself.